Additionally, we found that the levels of IL-6 were increased by 58-fold in lung cancer patients, which is also in line with previous studies that has reported a positive correlation of the increased levels of this cytokine and lymph node metastasis, distant metastasis and worse overall survival. This evidence concerns the gene IL6 and metastasis.